E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Under the terms of the agreement, Hanmi will receive an upfront payment of USD 190 million from Genentech.
imphoenix82
Lilly is calling on regulators, customs agencies, law enforcement authorities, online platforms, and payment companies to shut down the illegal retatrutide black market.
imphoenix82
Lilly sees retatrutide as part of a broader portfolio approach to obesity care alongside its existing therapies Zepbound (tirzepatide) and Foundayo (orforglipron).
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
